Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.8B | 16.9B | 13.9B | 20.3B |
Cost of revenue | 14.8B | 11.6B | 8.5B | 14.5B |
Gross profit | 7.9B | 5.3B | 5.5B | 5.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 986.3M | 202.3M | 481.8M | 402.8M |
Operating income | 4.9B | 3.1B | 2.9B | 3.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.2B | 1.1B | 1.1B | 1.0B |
Other income expense | — | — | — | — |
Pretax income | 5.0B | 3.5B | 2.6B | 2.2B |
Tax provision | 1.0B | 877.8M | 664.3M | 662.7M |
Net income | 4.0B | 2.6B | 1.9B | 1.6B |
Basic EPS | — | 27.1 | 20.0 | 16.1 |
Diluted EPS | — | 27.0 | 20.0 | 16.1 |
Basic average shares | — | 96.7M | 96.8M | 96.7M |
Diluted average shares | — | 96.8M | 96.9M | 96.8M |
EBITDA | 6.6B | 5.2B | 4.2B | 4.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 7.4M | -8.8M | 0 | -6.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |